Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation

As new bio/pharmaceutical manufacturing and development approaches move toward commercialization, traditional industry modalities are under intense pressure (1-7). At the same time, automation, advanced analytics, digital twins, artificial intelligence, and other technologies are evolving quickly and promising to transform how medicines are developed, produced, and delivered.